Twist Bioscience Files for $85 Million Offering of Common Stock

Twist Bioscience (NASDAQ: TWIST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced on 5/6/19 that it has commenced an underwritten public offering of 3,000,000 shares of its common stock.